Abstract:Disturbances of the microbiota–gut–brain axis are evident in people with Huntington's disease (HD) and in HD animal models. Here, we provide an overview of how the trillions of microorganisms residing in the gut, their secretory products, and the microbiota–gut–brain axis may contribute to HD pathogenesis. We discuss in depth the currently available therapeutic strategies targeting gut microbes, and their promising potential as non‐invasive, safe, and efficacious treatments for HD. Huntington's disease (HD) is a currently incurable neurogenerative disorder and is typically characterized by progressive movement disorder (including chorea), cognitive deficits (culminating in dementia), psychiatric abnormalities (the most common of which is depression), and peripheral symptoms (including gastrointestinal dysfunction). There are currently no approved disease‐modifying therapies available for HD, with death usually occurring approximately 10–25 years after onset, but some therapies hold promising potential. HD subjects are often burdened by chronic diarrhea, constipation, esophageal and gastric inflammation, and a susceptibility to diabetes. Our understanding of the microbiota–gut–brain axis in HD is in its infancy and growing evidence from preclinical and clinical studies suggests a role of gut microbial population imbalance (gut dysbiosis) in HD pathophysiology. The gut and the brain can communicate through the enteric nervous system, immune system, vagus nerve, and microbiota‐derived‐metabolites including short‐chain fatty acids, bile acids, and branched‐chain amino acids. This review summarizes supporting evidence demonstrating the alterations in bacterial and fungal composition that may be associated with HD. We focus on mechanisms through which gut dysbiosis may compromise brain and gut health, thus triggering neuroinflammatory responses, and further highlight outcomes of attempts to modulate the gut microbiota as promising therapeutic strategies for HD. Ultimately, we discuss the dearth of data and the need for more longitudinal and translational studies in this nascent field. We suggest future directions to improve our understanding of the association between gut microbes and the pathogenesis of HD, and other 'brain and body disorders'.

Inflammation and Huntington's disease – a neglected therapeutic target?

Neuroinflammatory Proteins in Huntington’s Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications

Neuroinflammation in Huntington's disease: From animal models to clinical therapeutics

Insights into Mechanisms, Diagnosis, and Therapeutic Implications

Classical HDACs in the Regulation of Neuroinflammation.

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.

Sex differences in Huntington's disease from a neuroinflammation perspective

Neuroinflammation and the role of epigenetic-based therapies for Huntington's disease management: the new paradigm

Huntington disease: natural history, biomarkers and prospects for therapeutics

Huntington's Disease: Molecular Basis of Pathology and Status of Current Therapeutic Approaches.

Therapy development in Huntington disease: From current strategies to emerging opportunities

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.

Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities

Progress in studies of gene therapy for Huntington's disease

Pain in Huntington’s Disease and Its Potential Mechanisms

The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets

Mediators and Lifestyle Interventions

Emerging antibody-based therapies for Huntington's disease: current status and perspectives for future development

Advances in Gene and Cellular Therapeutic Approaches for Huntington’s Disease

Neuroimmune pathways involvement in neurodegeneration of R6/2 mouse model of Huntington's disease